CIBTULA

Serial Number 90083021
606

Registration Progress

Application Filed
Jul 30, 2020
Under Examination
Feb 23, 2021
Approved for Publication
Dec 29, 2020
Published for Opposition
Dec 29, 2020
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: CIBTULA
Previous Owner: Corbus Pharmaceuticals, Inc.
Classes: 005

Trademark Image

CIBTULA

Basic Information

Serial Number
90083021
Filing Date
July 30, 2020
Published for Opposition
December 29, 2020
Abandonment Date
September 26, 2022
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 26, 2022
Classes
005

Rights Holder

Corbus Pharmaceuticals, Inc.

03
Address
500 River Ridge Drive
Norwood, MA 02062

Ownership History

Corbus Pharmaceuticals, Inc.

Original Applicant
03
Norwood, MA

Corbus Pharmaceuticals, Inc.

Owner at Publication
03
Norwood, MA

Legal Representation

Attorney
Jeffrey J. Ellison

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

17 events
Date Code Type Description Documents
Sep 26, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 26, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 25, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 23, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 23, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 23, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 12, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 10, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 10, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 10, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 23, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 29, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 29, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 9, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 20, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 18, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 28, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for the treatment of inflammatory diseases, fibrotic diseases, systemic sclerosis, dermatomyositis, systemic lupus erythematosus, and cystic fibrosis

Classification

International Classes
005